Scott May, PhD

VP Chemistry - Genetic Medicine at Eli Lilly and Company

Speaker

Scott May, Ph.D., is VP of Chemistry in Synthetic Molecule Design and Development (SMDD) at Eli Lilly and Company. He earned a B.S. in Chemistry from Hope College and a Ph.D. from Indiana University. Scott has led Lilly's efforts in Continuous Manufacturing and Oligonucleotide Synthesis, which have resulted in new facilities within development, manufacturing, and at external partners. His recent work focuses on transforming the synthesis of oligonucleotide therapeutics to reduce costs, minimize environmental impact, and improve patient access to advanced medicines in Lilly's portfolio.